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http://dx.doi.org/10.1016/j.stemcr.2016.07.015SUMMARYThe ability to reliably express fluorescent reporters or other genes of interest is important for using human pluripotent stem cells
(hPSCs) as a platform for investigating cell fates and gene function. We describe a simple expression system, designated GAPTrap
(GT), in which reporter genes, including GFP, mCherry, mTagBFP2, luc2, Gluc, and lacZ are inserted into the GAPDH locus in hPSCs.
Independent clones harboring variations of the GT vectors expressed remarkably consistent levels of the reporter gene. Differenti-
ation experiments showed that reporter expression was reliably maintained in hematopoietic cells, cardiac mesoderm, definitive
endoderm, and ventral midbrain dopaminergic neurons. Similarly, analysis of teratomas derived from GT-lacZ hPSCs showed that
b-galactosidase expression was maintained in a spectrum of cell types representing derivatives of the three germ layers. Thus, the
GAPTrap vectors represent a robust and straightforward tagging system that enables indelible labeling of PSCs and their differenti-
ated derivatives.INTRODUCTION
Constitutive expression of genes in pluripotent stem cells
(PSCs) and their differentiated progeny has been a critical
tool for studying gene function both in vivo and in vitro.
In the mouse, the most widely used system targets Rosa26,
a locus identified inanembryonic stemcell (ESC) gene-trap-
ping experiment (Zambrowicz et al., 1997). The original
Rosa26-lacZ reporter genedisplayedubiquitous and reliable
expression in all tissues of ESC-derived mice, prompting
researchers to subsequently modify this locus to enable
expression of other genes and genetic elements (Soriano,
1999). Although ubiquitously expressed loci in human
PSCs (hPSCs) have been described (Costa et al., 2005; Irion
et al., 2007), few studies have utilized these for overexpres-
sion or lineage-tracing studies. More recently, a number
of laboratories have reported successful introduction of
gene-expression cassettes into the Adeno-Associated Virus
1 (AAVS1) integration site locus (Luo et al., 2014; Qian
et al., 2014; Smith et al., 2008). In these studies, transgenes
in this locus maintain reliable expression in a number of
differentiated lineages and, in some instances, expression518 Stem Cell Reports j Vol. 7 j 518–526 j September 13, 2016 j ª 2016 The
This is an open access article under the CC BY license (http://creativecommocan be regulated through inclusion of tetracycline-respon-
sive elements (Hockemeyer et al., 2009; Sim et al., 2015).
The demonstrated utility of the AAVS1 system provides
impetus for the development of alternative expression plat-
forms, providing researchers with an opportunity to un-
dertake increasingly sophisticated experiments requiring
multiple genetic modifications.
The glyceraldehyde 3-phosphate dehydrogenase
(GAPDH) gene encodes a key component of the glycolytic
pathway, a process that turns glucose into ATP in all cells.
GAPDH is ubiquitously expressed at consistently high
levels in many different cell types, making it an ideal gene
upon which to base a gene-expression system (Barber
et al., 2005) (GTex Consortium, 2015; Murphy and Polak,
2002) (http://www.gtexportal.org/home/gene/GAPDH).
We have generated a series of vectors in which the expres-
sion of introduced genes is derived from the GAPDH tran-
script, ensuring high-level, widespread expression of the
transgene. In addition, our vector design links expression
of a selectable marker gene to integration dependent trap-
ping theGAPDH promoter, greatly enhancing the probabil-
ity of obtaining correctly targeted clones.Authors.
ns.org/licenses/by/4.0/).
RESULTS
The structure of this GAPTrap (GT) vector is shown in Fig-
ure 1A. Genes of interest are inserted in frame with a T2A
sequence (Szymczak and Vignali, 2005; Szymczak et al.,
2004) that replaces the GAPDH stop codon. An internal
ribosome entry site (Jang et al., 1990) located immediately
downstream is used to express selectable marker genes en-
coding neomycin, hygromycin, or puromycin resistance.
In the GT vectors, sequences encoding these antibiotic
resistance markers have been optimized for expression
in mammalian cells and are designated Meo, Mygro, and
Muro. Vectors, Addgene accession numbers and cell lines
generated for this study are listed in Table S1.
To assist with the generation of targeted clones, we
utilized transcription activator-like effector nucleases
(TALENs) (Wood et al., 2011; Hockemeyer et al., 2011) or
the CRISPR/Cas9 system directed against the point within
the GAPDH locus at which the vector is inserted. We found
that introduction of a double-stranded break using either
TALENs or CRISPRs was essential for the generation of
correctly targeted clones. Depending on the vector config-
uration, targeting efficiencies were often greater than 70%.
For example, GT-TdTom andGT-lacZ vectors gave targeting
frequencies of 10/12 (83%) and 9/10 (90%) when using
TALENs (see Figure S1C). Similarly, CRISPR/Cas9-assisted
homologous recombination yielded a targeting efficiency
of 80% (12/15) (Figure S1D). To ascertain the frequency at
which insertions and deletions (Indels) occurred in the
unmodified GAPDH allele of cells containing a GT vector,
we sequenced the region corresponding to the pointwithin
the GAPDH allele targeted by the GAPDH TALENs. This
analysis showed that of 24 GT-reporter lines, 25% had
Indels, indicative of non-homologous end-joining (NHEJ)
events. Given the relatively low frequency of on-target
NHEJ events in the GAPDH locus itself, the presence of
off-target cutting events by this pair of TALENs was not
assessed.
GAPDH functions as a tetramer, and examination of the
3D crystal structure indicated that the C terminus of each
GAPDH subunit is located on the exterior surface of the
tetramer (Ismail and Park, 2005), suggesting that additional
amino acids encoded by the T2A sequence should not
interfere with enzymatic activity. However, examination
of GAPDH protein using western blot analysis indicated
that modified alleles that include an internal ribosome
entry site (IRES)-selectable marker cassette were expressed
at lower levels than the wild-type GAPDH allele. Thus,
although we expect the specific activity of GAPDH-T2A
proteins to be the same as that of the wild-type protein,
the reduced expression of GAPDH-T2A from the modified
allele may explain why cells with two targeted GAPDH
alleles could not be isolated (Figure S1E).Using the vectors shown in Figure 1A, we generated
a series of PSC lines that expressed EGFP (Cormack et al.,
1996), Clover (Lam et al., 2012), mCherry (Merzlyak
et al., 2007), mtagBFP2 (Subach et al., 2011), Tandem
tomato (tdTomato) (Shaner et al., 2004), luciferase 2
(Luc2) (Promega), a membrane-bound Gaussia princeps
luciferase (GLuc) (Santos et al., 2009), and nuclear LacZ
(Stanley et al., 2000) (Table S1). Cells expressing the fluores-
cent markers could be readily visualized by microscopy
(Figure 1B).
Flow cytometry analysis showed that independent
targeted clones expressed remarkably similar levels of
the inserted reporter genes, highlighting the consistency
of expression produced by this vector configuration
(Figure 1C). This consistency also enabled us to conclude
that all the selectable marker genes adversely affected
expressionof theupstreamfluorescent reporter (FigureS1F).
Intracellular flow cytometry of GT-Luc2 H9 cells showed
that independent clones also expressed Luc2 at consistent
levels while transplantation experiments indicated expres-
sion was sufficient to observe subcutaneously grafted cells
using bioluminescent imaging (Figure 1D). Similarly, sur-
face expression of GLuc could be detected on GT-GLuc
iPSCs using flow cytometry, and consistent levels of GLuc
activity could be readily assayed on live cells (Figure 1E).
We examined the reliability of expression during the
differentiation to derivatives of the three embryonic germ
layers, mesoderm, endoderm, and ectoderm. These studies
indicated that robust expression was maintained when
GT-GFP H9 hESCs or GT-tdTomato iPSCs were differenti-
ated to hematopoietic mesoderm, with readily detectable
expression in individual hematopoietic cells by fluores-
cence microscopy and flow cytometry (Figures 2A, 2B,
and S2A). Similarly, tdTomato expression from the GAPDH
locus (GT-TdTom) was maintained at robust levels in
cardiac mesoderm at differentiation day 7, identified by
expression of GFP from the NKX2-5 locus (Elliott et al.,
2011) (Figure 2C). Bright GT-tdTomato expression was
also observed in CXCR4+EpCAM+ definitive endoderm
cells at differentiation day 4 (Figures 2D and S2B), with
expression levels similar to that seen in undifferentiated
GT-tdTomato PSCs (Figure 2E). Using a neural differentia-
tion protocol, we observed strong and consistent tdTomato
expression in tyrosine hydroxylase (TH)-positive ventral
midbrain dopamine neurons at differentiation day 30 (Fig-
ure 2F, see also GT-GFP expression in Figure S2C).
To further explore the spectrum of cell types that ex-
pressed the GT-reporter system, we generated teratomas
from GT-lacZ PSCs by subcutaneous injection of 106 un-
differentiated cells into NOD/SCID/IL2Rg null mice
(Shultz et al., 2005). After 2–3 months, palpable teratoma
masses were removed, fixed in paraformaldehyde, and sub-
sequently stained with X-gal to reveal cells expressingStem Cell Reports j Vol. 7 j 518–526 j September 13, 2016 519
Figure 1. Structure and Function of the GAPTrap Vectors and Selected Variants
(A) GAPTrap (GT) vector structure relative to the GAPDH locus. The upper line represents the GAPDH locus with exons shown as gray boxes,
with the promoter (P) and position of the TALEN target sites marked. The middle line shows the GT targeting vector, comprising from 50 to
30: a 50 GAPDH homology arm, a T2A peptide sequence (2A) fused in frame with the GAPDH coding sequence, the gene of interest (Gene), an
internal ribosomal entry site (I), a selectable marker (S), and a 30 GAPDH homology arm. The lower line shows the structure of the modified
GAPDH locus, with the genes tested in this study shown below. These are EGFP (GFP), mCherry, mtagBFP2 (BFP), Tandem tomato (TdTom),
Gaussia luciferase (GLuc), firefly luciferase (Luc2), b-galactosidase (LacZ), and Clover. The three selectable markers (S) encoding hy-
gromycin (Mygro), G418 (Meo), and puromycin (Muro) are also shown. Asterisk denotes that in the GT-Clover vector the selectable marker
is positioned after a second T2A sequence.
(B) Confocal microscopy fluorescence images of undifferentiated hPSCs expressing Clover, Tandem tomato, mtagBFP2, and GFP. Scale bars,
200 mm.
(C) Flow cytometry histograms showing clone-to-clone consistency of expression for three independent hPSC lines containing GT-Clover,
GT-mCherry, GT-BFP vectors.
(D) Intracellular flow cytometry of three independent hPSC lines containing the GT-Luc2 expression cassette (left) and the results of
bioluminescent imaging showing a localized signal from GT-Luc2 hPSCs transplanted subcutaneously in an immunodeficient mouse (8 days
post transplant) (right).
(E) Flow cytometry histograms showing clone-to-clone consistency for three independent hPSC lines expressing Gaussia luciferase (GLuc)
(left) and a summary of results of luciferase assays for the three GT-GLuc clones. The graph shows the mean relative expression and the SEM.
Luciferase activity is absent from the unmodified parental iPSC.
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Figure 2. Maintenance of Reporter Expression during Differentiation of GAPTrap hPSCs
(A) Fluorescence images of GFP-expressing day-14 hematopoietic colonies formed in methylcellulose. The right panel shows that indi-
vidual blood cells can be readily identified (white arrow). Scale bars, 100 mm.
(B) Flow cytometry analysis showing that all cells isolated from the cultures in (A) maintain GFP expression.
(C) Flow cytometry analysis of differentiation day 10 NKX2-5+ cardiomyocytes derived from parental and GT-TdTom tagged hESCs.
(D) Differentiation of GT-TdTom iPSCs to CXCR4+EpCAM+ endoderm shows that Tandem tomato (tdTom) expression is clearly detectable by
fluorescence microscopy and is maintained at uniform levels, as determined by flow cytometry. Scale bars, 200 mm.
(E) Flow cytometry histograms showing that the level of Tandem tomato expression is similar in undifferentiated (Undiff) GT-TdTom iPSCs
and their endodermal derivatives.
(F) Fluorescence microscopy images showing expression of GT-TdTom in tyrosine hydroxylase (TH)-positive neurons at differentiation day
30. The TdTom panel shows Tandem tomato fluorescence following fixation and processing for antibody staining with anti-TH antibodies.
DAPI was used to visualize nuclei. Scale bars, 100 mm.
(G–I) Bright-field images of eosin-counterstained sections from teratomas derived from GT-lacZ iPSCs that were stained with X-gal to
reveal lacZ activity prior to sectioning. Arrowheads indicate cartilage (mesoderm) (G), goblet cells (endoderm) (H), and pigmented
epithelium (ectoderm) (I). Scale bars, 100 mm.
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b-galactosidase activity. This analysis revealed that the
surface of teratomas and the surface of dissected teratoma
subfragments stained strongly and uniformly with X-gal
(Figure S2D). Examination of eosin-stained sections re-
vealed a variety of differentiated tissue types, including
cartilage (Figure 2G), epitheliumcontaining goblet-like cells
and surrounding mesenchyme (Figure 2H), and pigmented
epithelium (Figure 2I) that displayed strong X-gal staining,
suggesting theGT-lacZ transgenecontinued tobe expressed,
even after an extended period of differentiation in vivo.DISCUSSION
We have generated a series of vectors designated GAPTrap,
or GT, based on the GAPDH locus, a ubiquitously and
robustly expressed housekeeping gene. We have con-
structed and tested a range of reporters and have shown
that their expression is maintained in a wide variety of
cell types, and for longer than 2 months in vivo, making
the system ideal for the long-term tracking of cells in vitro
and subsequent transplantation. In addition to commonly
used fluorescent proteins, we have tested a number of other
reporters we believe will be useful for in vivo cell tracking.
For example, luciferase (Luc2) allows the visualization of
cells in living animals using bioluminescent imaging. As
stem cell technologies transit the preclinical testing phase
of development, such imaging systems will be useful for
understanding thebehavior of differentiated cells in animal
models. We also found that a previously described surface-
directed luciferase, GLuc (Santos et al., 2009), was robustly
expressed, despite the fact that the signal sequence required
for trafficking to the cell membrane was C-terminal of
cytoplasmic GAPDH. Lastly, we have illustrated how a
GT-lacZ expression system enables the simple detection of
PSC-derived cells in a context compatible with standard
paraffin-embedded histological sections.
In addition to configurations for constitutive gene
expression, we also tested the behavior of the Tet-on
system (http://www.clontech.com) in which sequences
encoding either GFP or mCherry expression were placed
under the control of a doxycycline-responsive promoter.
Although robust doxycycline-inducible expression was
observed in early passage lines, the vectors eventually un-
derwent silencing. It is not clear whether this silencing
was an inherent property of the genomic position of the
transgene or a function of the vector configuration. What-
ever the underlying mechanism, silencing or variegated
expression of transgenes that contain either inducible or
tissue-specific promoters seems to be an issue affecting
other ‘‘safe harbor’’ loci (Ordovas et al., 2015).
Taking into account the 3D structure of GAPDH, we
hypothesized that the presence of 2A peptide at the C ter-522 Stem Cell Reports j Vol. 7 j 518–526 j September 13, 2016minus would not interfere with GAPDH function. How-
ever, western blot analysis indicated a clear reduction in
the level of GAPDH-T2A protein relative to GAPDH protein
translated from the unmodified GAPDH allele. Analysis of
different vector configurations suggested that this lower
level of expression was in part due to sequences down-
stream of the reporter gene. We observed that expression
of GFP from different variants of the GT vectors differed
substantially, depending on the sequence of the selectable
marker 30 of the IRES. Indeed, in vectors that lacked the
IRES-selectable marker cassette altogether, the intensity
of GFP was almost ten times brighter than in cells contain-
ing a GT vector that included the IRES-Mygro cassette
(Figure S1E). However, all PSCs containing the GT vector
efficiently differentiated into a variety of lineages, suggest-
ing that the presence of the genetic modification did not
impinge on differentiation potential.
In conclusion, the GT vector system is a reliable option
for the constitutive expression of genes in PSCs and their
differentiated derivatives. The vectors complement exist-
ing expression systems and therefore will enable the imple-
mentation of complex multifaceted genetic modifications
that require several independent elements. The ease with
which hPSCs can be modified using GT vectors should
facilitate tagging, tracking, and overexpression studies in
both in vivo and in vitro experiments.EXPERIMENTAL PROCEDURES
Vectors, TALENs, and CRISPRs
Vectors and cell lines described in this report can be obtained
by contacting the authors (ed.stanley@mcri.edu.au or andrew.
elefanty@mcri.edu.au). Some vectors will also be available through
Addgene (see Table S1), and may be located using the search term
GAPTrap. The base GT vectors were constructed as follows.
Genomic homology arms were amplified from human genomic
DNA using primers and cloned into Topoblunt cloning vectors
(Invitrogen). Cloned fragments representing the 50 arm were
sequenced to ensure the GAPDH coding sequence was free from
PCR-induced mutations. The 50 arm was cloned upstream of the
30 arm to create base vectors into which cassettes constituting an
IRES (Wu et al., 1994) and selectablemarker genewere inserted. An-
notated sequences of these base vectors are available in GenBank
(GAPTrap-IRESMygro, GAPTrap-IRESMuro, GAPTrap-IRESMeo).
The Mygro, Meo, and Muro coding sequences were synthesized to
order by GenScript (http://www.genscript.com). Individual varia-
tions derived from the base vectors, as described in Table S1, are
available upon request from the authors. Reporter geneswere intro-
duced into specific base vectors using either conventional cloning
or infusion cloning (http://www.clontech.com). In either case,
the sequence of the inserted reporter was determined by Sanger
sequencing (performed by the Australian Genome Research Facil-
ity) and continuity of the translational reading frame from the
GAPDH coding region, through the 2A sequence to the inserted
reporter, was examined using DNAStar (http://www.dnastar.com)
or Snapgene (http://www.snapgene.com) DNA analysis software.
TALENs against the GAPDH locus were designed and assembled
byCellectis Biosearch (http://www.cellectis.com/en/). The TALENs
targeted sequences immediately 30 of the GAPDH stop codon as
shown below. The coding sequence of GAPDH is underlined.
Sequences bound by the left (50) and right (30) TAL effector DNA
binding domains are in shown in UPPER CASE. Sequences cut
by the TALEN pair are italicized lower case.
50.tcttttcatcttctaggtatgacaacgaatttggctacagcaacagggtggtggacctc
atggcccacatggccTCCAAGGAGTAAGACCCctggaccaccagccccagcaa
GAGCACAAGAGGAAGAGAgagaccctcactgctggggagtccctgccacac
tcagtcccccaccacactgaatctcccctcctcacagtttccatgtagaccccttgaagagggg
agg.30.
Analysis of the TALEN binding sites indicate that this pair of
TALENs would also cut two GAPDH pseudogenes located on chro-
mosome 13 and on the X chromosome. PCR analysis failed to
detect any transgene integration at these sites, perhaps because
antibiotic resistance of transfected cells requires trapping of an
active transcription unit. Integration of the GT vectors at these
sites may also be inhibited by the imperfect alignment of the pseu-
dogenes with the homology arms of the GAPTrap vectors.
For the CRISPR/CAS9 experiments, synthetic oligonucleotides
containing the desired GAPDH protospacer sequence (CTTCC
TCTTGTGCTCTTGCT) were annealed to generate a duplex with
overhangs compatible with those generated by BbsI digestion of
the sgRNA expression plasmid described previously (Howden
et al., 2015). To enable in vitro transcription of mRNA encoding
CAS9, we inserted an XbaI-NsiI fragment from plasmid hCas9
(Addgene plasmid #41815) containing the entire SpCas9 sequence
into the NheI and SbfI sites of the pDNR-Dual vector (Clontech) to
generate pDNR-SpCas9.
In Vitro Transcription
Capped and polyadenylated in vitro transcribed mRNA encoding
CAS9 was generated using the mMESSAGE mMACHINE T7 ULTRA
transcription kit (Thermo Fisher) according to the manufacturer’s
recommendations. Plasmid template was linearized with PmeI
prior to transcription. LiCl was used to precipitate mRNA before
resuspension.
Transfection
For targeting experiments using the CRISPR/Cas9 system, transfec-
tionswereperformedusing theNeonTransfection System (Thermo
Fisher).H9 cellswere harvestedwithTrypLE (ThermoFisher) 2 days
after passaging and resuspended in buffer R at a final concentration
of 13 107 cells/mL.One hundredmicroliters of the cell suspension
was added to a tube containing circular GT-BFP-IRESMuro vector,
mRNA encoding Cas9, and the GAPDH-specific gRNA expression
vector. Electroporation was performed in a 100-mL tip using the
following conditions: 1,100 V, 30ms, 1 pulse. Following electropo-
rationcellswere transferred toMatrigel-coatedplates containingE8
medium supplemented with 5 mM Y-27632 (Tocris), which was
omitted in subsequent media changes. Puromycin was added to
medium after 4 days to isolate correctly targeted clones.Human PSC Culture and Genetic Modification
RM3.5 iPSCs were derived from human foreskin fibroblasts
purchased from ATCC and reprogrammed using the hSTEMCCA-loxP four-factor lentiviral vector as described previously (Somers
et al., 2010). Following isolation of iPSCs, integrated vector se-
quenceswere removedusing cre recombinase as described byDavis
et al. (2008). PSCs, H9 (Thomson et al., 1998), NKX2-5GFP/w HES3
(Elliott et al., 2011), and the iPSC line, RM3.5, were cultured as
described by Costa et al. (2008) and genetic modifications carried
out as outlined by Costa et al. (2007) with the following modifica-
tions. Cells were electroporated with 10–20 mg of targeting vector
and 5 mg of eachGAPDH-specific TALEN plasmid. GAPTrap vectors
were linearized with Pac1 prior to electroporation, or delivered
as uncut circles. Antibiotic selection was commenced between 2
and 5 days post electroporation, using either 75 mg/mL hygromy-
cin (GT-Myrgo vectors), 75 mg/mL G418 (GT-Meo vectors), or
1 mg/mL puromycin (GT-Muro vectors). G418 and hygromycin se-
lection were continued for 7–14 days while puromycin selection
was applied for 2–7 days. Antibiotic-resistant clones were picked,
expanded, and cryopreserved (Costa et al., 2007). For vectors
without a selectable marker, hPSCs were electroporated, and
GFP-expressing single cells were isolated by FACS after 2–5 days us-
ing a BD Influx cell sorter (http://www.bdbiosciences.com/in/
instruments/influx/index.jsp) as described by Davis et al. (2008).
Individual GFP-expressing clones were expanded for further
analysis.
Analysis of Genomic Integrity, Characterization, and
Differentiation
Genomic integrity of selected genetically modified lines was as-
sessed using the Illumina HumanCytoSNP-12 v2.1 array and was
performed by the Victorian Clinical Genetics Service, Royal Chil-
dren’s Hospital (Melbourne) or by standard karyotype analysis as
described previously. Selected individual clones were examined
for expression of EPCAM and CD9 expression using flow cytome-
try (Figure S1A; antibodies are listed in Table S2). GT-lacZ iPSC lines
were tested for pluripotency using a teratoma assay (Gropp et al.,
2012). Endoderm differentiation was performed in AEL medium
(Ng et al., 2008) using the factor combinations and timing reported
by Loh et al. (2014). Hematopoietic differentiation was performed
using the Spin EB method (Ng et al., 2008). Cardiomyocytes were
generated using a modification of the method reported by Lian
et al. (2012) and Skelton et al. (2014), with the additional change
that 5 mM IWR1 (Sigma i0161) was used in place of IWP2. TH-pos-
itive neurons were generated as previously described (Kriks et al.,
2011) except that cells were cultured on mTESR2 and differentia-
tion initiated on laminin-521 at 10 mg/ml (Biolamina, as per man-
ufacturer’s instructions) or vitronectin at 10 mg/ml (STEMCELL
Technologies).
Flow Cytometry and Western Blotting
For flow cytometry analysis of cell surface marker expression,
embryoid bodies or adherent cultures were washed with PBS and
dissociated with TrypLE Select (www.thermofisher.com/order/
catalog/product/12563011) for 2–10 min at 37C to generate a
single cell suspension. TrypLE Select digestion was terminated
by addition of 5–10 volumes of PBS and the cells collected by
centrifugation. The cell pellet was resuspended in FACS buffer
(PBS with 2% fetal calf serum) with the diluted antibody (see
Table S2) added. Antibody binding was allowed to proceed forStem Cell Reports j Vol. 7 j 518–526 j September 13, 2016 523
up to 30 min on ice. Samples were then washed twice with 5 mL
of PBS and the pellet resuspended in FACS buffer containing
1 mg/ml propidium iodide. Samples were analyzed with a Becton
Dickinson FACSCalibur or LSRFortessa. Cells for intracellular
flow cytometry were collected as above and then processed using
a BD Cytofix/Cytoperm Kit according to the manufacturer’s in-
structions. Cells were labeled with a mouse anti-luciferase anti-
body (Abcam), which was subsequently detected with an APC-
conjugated goat anti-mouse secondary antibody, as described
by Mossman et al. (2005).
Bioluminescent Imaging and Teratoma Assays
For in vivo imaging, approximately 106 GT-Luc2 PSCs were trans-
planted subcutaneously into NOD/SCID/IL2Rg-null mice (Shultz
et al., 2005). Eight days post transplantation, mice were adminis-
tered 150 mg/g of VivoGlo luciferin (Promega) by intraperitoneal
injection. Five minutes after administration of luciferin, mice
were anesthetized by inhalation of isoflurane (2% in oxygen) for
5 min and then imaged using a Xenogen IVIS-200 imaging system
(Caliper). Images obtained were processed using Living Image soft-
ware (Caliper) to normalize luciferase expression data collected
across multiple time points.
Teratomas for GT-lacZ iPSCs were initiated by subcutaneous
injection of 106 cells as described by Gropp et al. (2012). After
4–6 weeks, mice harboring a palpable mass at the injection site
were killed by cervical dislocation, and the teratoma resected and
fixed in 4% paraformaldehyde (PFA). Teratoma fragments were
stained with X-gal as described, post-fixed in 4% PFA, embedded
in paraffin, and processed for histology. Sections were stained
with eosin. Mouse work was covered by institutional animal ethics
approvals A788 (Murdoch Children’s Research Institute) and
SOBSA/MIS/2009/107 (Monash University).
Immunofluorescence and Luciferase Assays
Immunofluorescence for the neural marker genes TH and FOXA2
was performed as described by Niclis et al. (2013) using the anti-
body dilutions described in Table S2. Assays for Gaussia luciferase
was conducted using coelenterazine (CTZ) substrate (Nanolight)
as described by the supplier. Approximately 103 cells repre-
senting three independently derived GT-GLuc iPSCs (and con-
trols) were assayed without lysis and light emission measured
at 475 nm.
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